Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Abstract

Oral anticoagulation is the optimal choice of antithrombotic therapy for patients with AF at high risk of stroke (CHADS(2) score of ≥ 2). At lower levels of stroke risk, antithrombotic treatment decisions will require a more individualized approach.

Full Text

DOI - (DOI)
Ovid Technologies, Inc. - full-text online
MD Consult - full-text online
HighWire Press - full-text online

Subjects

Administration, Oral
Anticoagulants
Aspirin
Atrial Fibrillation
Atrial Flutter
Benzimidazoles
Dose-Response Relationship, Drug
Drug Therapy, Combination
Electric Countershock
Evidence-Based Medicine
Fibrinolytic Agents
Hemorrhage
Humans
International Normalized Ratio
Risk Factors
Societies, Medical
Stroke
Ticlopidine
Vitamin K
beta-Alanine

Authors

Publication date

2012-02-08

Journal

Chest
Chest (1931-3543)

Journal topics

Language

Eng.

Copyright

Department of Medicine, McMaster University, Hamilton, ON, Canada.

Release reference

Chest. 2012 Feb;141(2 Suppl):e531S-75S